Comparison Chart Cellectar Biosciences, Inc.

CLRB

US15117F8804

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CELLECTAR BIOSCIENCES, INC.	Other Pharmaceuticals	-1.23%	-1.23%	-59.15%	-64.45%	-99.53%	11.39M

10-27	Cellectar Biosciences Reports Case Study Highlighting Complete Response Lasting More Than Eight Years in Heavily Pretreated DLBCL Patient Treated With Iopofosine I 131	CI
10-15	Cellectar Biosciences, Inc. Presents Efficacy Results From Phase 2b CLOVER WaM Subset Analysis Of Iopofosine I 131 In Patients Relapsed/Refractory To BTK Inhibitor Therapy	CI

Market Closed - Nasdaq 00:00:00 31/10/2026 +04			5-day change	1st Jan Change
1.205 ^USD	-1.23%		-1.23%	-59.15%

Comparison Chart Cellectar Biosciences, Inc.

Stocks

CLRB

US15117F8804

Pharmaceuticals

Compared values